tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market

Coherus Biosciences (CHRS) Income Statement

Compare
1,554 Followers

Coherus Biosciences Income Statement

Last quarter (Q3 2024), Coherus Biosciences's total revenue was $70.77M, a decrease of -5.09% from the same quarter last year. In Q3, Coherus Biosciences's net income was $-10.75M. See Coherus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 257.24M$ 211.04M$ 326.55M$ 475.82M$ 356.07M
Gross Profit
$ 94.46M$ 140.96M$ 268.96M$ 438.16M$ 338.99M
Operating Expenses
$ 301.45M$ 397.84M$ 532.82M$ 281.84M$ 231.22M
Depreciation and Amortization
$ 3.79M$ 3.70M$ 5.66M$ 4.97M$ 3.26M
EBITDA
$ -193.94M$ -255.58M$ -260.69M$ 161.84M$ 111.03M
Operating Income
$ -203.20M$ -256.88M$ -263.86M$ 156.32M$ 107.77M
Other Income/Expenses
$ -35.07M$ -34.87M$ -23.24M$ -20.61M$ -14.99M
Pretax Income
$ -238.27M$ -291.75M$ -287.10M$ 135.71M$ 92.78M
Net Income
$ -237.89M$ -326.63M$ -306.32M$ 132.24M$ 89.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.53$ -4.21$ -4.06$ 1.85$ 1.29
Diluted EPS
$ -2.53$ -4.21$ -4.06$ 1.62$ 1.23
Weighted Average Shares Outstanding
94.16M 77.63M 75.45M 71.41M 69.68M
Weighted Average Shares Outstanding (Diluted)
94.16M 77.63M 75.45M 83.49M 73.19M
Currency in USD

Coherus Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis